Conmed (CNMD) Misses Q3 EPS by 6c, Lowers FY Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Leerink Partners Cuts Price Target as Conmed (CNMD) Reports 6c EPS Miss
October 22, 2015 8:53 AM EDTLeerink Partners reiterated an Outperform rating on CONMED (NASDAQ: CNMD), and cut the price target to $53.00 (from $60.00), following the company's 3Q15 earnings results. 3Q revenues of $169M were below consensus' $173M estimate. EPS of $0.38 was below $0.44 estimate.
Analyst Richard Newitter commented,... More
